Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection

DSpace/Manakin Repository

Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection

Citable link to this page

 

 
Title: Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection
Author: Vergani, Andrea; Fotino, Carmen; D’Addio, Francesca; Tezza, Sara; Podetta, Michele; Gatti, Francesca; Chin, Melissa; Bassi, Roberto; Molano, Ruth D.; Corradi, Domenico; Gatti, Rita; Ferrero, Maria E.; Secchi, Antonio; Grassi, Fabio; Ricordi, Camillo; Sayegh, Mohamed H.; Maffi, Paola; Pileggi, Antonello; Fiorina, Paolo

Note: Order does not necessarily reflect citation order of authors.

Citation: Vergani, A., C. Fotino, F. D’Addio, S. Tezza, M. Podetta, F. Gatti, M. Chin, et al. 2013. “Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection.” Diabetes 62 (5): 1665-1675. doi:10.2337/db12-0242. http://dx.doi.org/10.2337/db12-0242.
Full Text & Related Files:
Abstract: The lymphocytic ionotropic purinergic P2X receptors (P2X1R-P2X7R, or P2XRs) sense ATP released during cell damage-activation, thus regulating T-cell activation. We aim to define the role of P2XRs during islet allograft rejection and to establish a novel anti-P2XRs strategy to achieve long-term islet allograft function. Our data demonstrate that P2X1R and P2X7R are induced in islet allograft-infiltrating cells, that only P2X7R is increasingly expressed during alloimmune response, and that P2X1R is augmented in both allogeneic and syngeneic transplantation. In vivo short-term P2X7R targeting (using periodate-oxidized ATP [oATP]) delays islet allograft rejection, reduces the frequency of Th1/Th17 cells, and induces hyporesponsiveness toward donor antigens. oATP-treated mice displayed preserved islet grafts with reduced Th1 transcripts. P2X7R targeting and rapamycin synergized in inducing long-term islet function in 80% of transplanted mice and resulted in reshaping of the recipient immune system. In vitro P2X7R targeting using oATP reduced T-cell activation and diminished Th1/Th17 cytokine production. Peripheral blood mononuclear cells obtained from long-term islet-transplanted patients showed an increased percentage of P2X7R+CD4+ T cells compared with controls. The beneficial effects of oATP treatment revealed a role for the purinergic system in islet allograft rejection, and the targeting of P2X7R is a novel strategy to induce long-term islet allograft function.
Published Version: doi:10.2337/db12-0242
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636636/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12407037
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters